Nemes Rush Group LLC Purchases 1,438 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Nemes Rush Group LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,694 shares of the healthcare conglomerate's stock after acquiring an additional 1,438 shares during the quarter. Nemes Rush Group LLC's holdings in UnitedHealth Group were worth $7,939,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $32,000. Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth $40,000. Finally, DecisionPoint Financial LLC increased its stake in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Finally, Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $629.32.

Remove Ads

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm's stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $0.49 during trading on Wednesday, reaching $523.61. 2,368,702 shares of the company's stock traded hands, compared to its average volume of 4,265,457. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market capitalization of $478.95 billion, a P/E ratio of 33.78, a PEG ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm's 50-day moving average is $509.06 and its 200 day moving average is $542.96.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the previous year, the business earned $5.83 earnings per share. The firm's quarterly revenue was up 6.8% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.